genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Special Report
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Cancer
Alpine’s Gold Standard Approach to Drug Development
Biomarkers
Precision M&A: Invitae Eyes Growth in Personalized Cancer Tests, Services with…
Gene Therapy
Obsidian’s SWFT Response to COVID-19
Antibody Drug Conjugates
AbCellera’s CEO: Flattening the Curve of Technology Development
Cancer
After Final Medicare LCD from Palmetto GBA, OncoCyte Pursues Private Coverage…
News
Alzheimers
New Method for Treating Myelin Disorders Discovered
Cancer
Novel Liver Cancer Mechanism Controls Development of Disease
Diabetes
Ultrafast, Stable Insulin Developed Thanks to Some “Magic Fairy Dust” Polymer…
CRISPR-Cas9
CRISPR Tool, in “CARPID Diem” Spirit, Detects RNA-Protein Interactions in Living…
Cancer
Chemotherapy Can Trigger Blood Vessel Anomalies Leading to Drug Resistance
Insights
All
Trends for 2020
Gene Therapy
Moving Forward after Two Deaths in a Gene Therapy Trial of…
Bioprocessing
Bioprocess 4.0 Approach Will Help Biopharma Achieve Regulators’ Goals
Bioprocessing
Digitalized Twin Model of the Workhorse
Bioprocessing
Mitigating Viral Contamination, a Challenge for Emerging Therapies
A-Lists
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Coronavirus
Blinking Red: 25 Missed Pandemic Warning Signs
Coronavirus
Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development
Coronavirus
Catching Up to Coronavirus: Top 60 Treatments in Development
Drug Discovery
Top 15 Best-Selling Drugs of 2019
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Gene Therapy
Moving Forward after Two Deaths in a Gene Therapy Trial of…
Cancer
Novel Liver Cancer Mechanism Controls Development of Disease
CRISPR-Cas9
CRISPR Tool, in “CARPID Diem” Spirit, Detects RNA-Protein Interactions in Living…
Cancer
Chemotherapy Can Trigger Blood Vessel Anomalies Leading to Drug Resistance
Magazine
All
Special Report
June 2020 Vol. 40 No. 6
The Human Genome Project in 2020 Hindsight
Commentary
3D Microscopy Keeps Getting Faster, Smarter, Leaner
Roundtable
Perspectives on Microscopy
Bioprocessing
Biomanufacturers Cope with Challenges of Going Continuous
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
eBooks
IsoPlexis’ Unique, Predictive Biology
eBooks
Engineering the Immune Response for Therapeutic Success
Upcoming Webinars
Packaging and Producer Cell Lines for Scalable Lentiviral Production
CRISPR-Cas9
GENcast: CRISPR Screens Speed Drug Discovery Efforts for Disease Intervention
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Biodefense/Bioterrorism
Biodefense/Bioterrorism
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Biodefense/Bioterrorism
Intranasal Anthrax Vaccine Candidate “Off to the Races”
Biodefense/Bioterrorism
Removing Anthrax Bacterial Armor May Lead to New Therapies
Biodefense/Bioterrorism
Spero Wins Up to $54M Toward Development of Lead Antibiotic SPR994 for UTI
Biodefense/Bioterrorism
Bavarian Nordic Wins Up-to-$36M DoD Contract toward Equine Encephalitis Vaccine
Biodefense/Bioterrorism
GMO Safety Factor Prevents Fruitful Interbreeding in the Wild
Biodefense/Bioterrorism
Bavarian Nordic Wins Up-to-$539M BARDA Contract for Smallpox Vaccine
Biodefense/Bioterrorism
Emergent Wins $63M BARDA Contract for Cyanide Antidote Spray Device
Biodefense/Bioterrorism
U.S. DOD to Start New Trial with Pluristem’s PLX-R18 Cell Therapy...
Biodefense/Bioterrorism
Malware Hidden in Synthetic DNA Could Infect Sequencing Systems
Biodefense/Bioterrorism
MerLion, Dstl Score DTRA Grant to Support Biothreat Antibiotic Development
Biodefense/Bioterrorism
Emergent Confirms $100M BARDA Contract for Anthrax Vaccine Stockpiling
Biodefense/Bioterrorism
Pluristem, NYBC Win $900K to Test PLX-R18 Cells Alongside Cord Blood...
Biodefense/Bioterrorism
DNA Electronics Wins Up-to-$51.9M BARDA Contract
Biodefense/Bioterrorism
Profusa Wins $7.5M DARPA Biosensor Grant
Biodefense/Bioterrorism
Allergan and AstraZeneca Commit to Antibiotic Development Deal
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
